Sandu Pharmaceuticals Limited (BOM:524703)

Sandu Pharmaceuticals Revenue

Sandu Pharmaceuticals had revenue of 187.61M INR in the quarter ending December 31, 2025, with 2.11% growth. This brings the company's revenue in the last twelve months to 671.50M, down -2.29% year-over-year. In the fiscal year ending March 31, 2025, Sandu Pharmaceuticals had annual revenue of 671.92M, down -0.13%.

• Revenue (ttm): 671.50M
• Revenue Growth: -2.29%
• P/S Ratio: 0.50
• Revenue / Employee: 2.22M
• Employees: 303
• Market Cap: 338.33M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	671.92M	-883.00K	-0.13%
Mar 31, 2024	672.81M	19.32M	2.96%
Mar 31, 2023	653.49M	-1.52M	-0.23%
Mar 31, 2022	655.01M	67.45M	11.48%
Mar 31, 2021	587.55M	103.10M	21.28%